VP
venBio Partners Portfolio holdings
AUM
$115M
This Quarter Return
+22.05%
1 Year Return
-33.99%
3 Year Return
+221.07%
5 Year Return
+224.54%
10 Year Return
–
AUM
$120M
AUM Growth
+$120M
(+2.5%)
Cap. Flow
-$21.2M
Cap. Flow
% of AUM
-17.63%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
1
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
Precision BioSciences
DTIL
|
$10.1M |
| 2 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$7.16M |
| 3 |
VYNE Therapeutics
VYNE
|
$3.92M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Akero Therapeutics
AKRO
$3.74B
| $78.5M | 65.27% | 3,150,019 | – | – |
|
|
2
Precision BioSciences
DTIL
$57.8M
| $23.3M | 19.33% | 2,791,578 -1,216,323 | -30% | -$10.1M |
|
3
Apellis Pharmaceuticals
APLS
$3.48B
| $16.4M | 13.62% | 501,584 | – | – |
|
|
VRNA
4
Verona Pharma
VRNA
$9.16B
| $2.14M | 1.78% | 456,770 | – | – |
|
|
5
VYNE Therapeutics
VYNE
$8.16M
| – | – | -1,461,552 | Closed | -$3.92M |
|
|
TPTX
6
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| – | – | -160,333 | Closed | -$7.16M |
|